Temocillin and meropenem to discriminate resistance mechanisms leading to decreased carbapenem susceptibility with focus on OXA-48 in Enterobacteriaceae

Clinical Microbiology and Infection

Volumn 19, Issue 5, 2013, Pages

  Hartl, R ^a,b   Widhalm, S ^b   Kerschner, H ^a,b   Apfalter, P ^a,b  

^a ELISABETHINEN HOSPITAL   (Austria)

^b Analyse BioLab GmbH   (Austria)

Author keywords

Carbapenemase; OXA 48; Temocillin

Indexed keywords

BACTERIAL ENZYME; BETA LACTAMASE; BETA LACTAMASE AMPC; CARBAPENEM; CARBAPENEMASE; MEROPENEM; PROTEIN OXA 48; TEMOCILLIN; UNCLASSIFIED DRUG;

ALGORITHM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CITROBACTER FREUNDII; CONTROLLED STUDY; DRUG POTENTIATION; ENTEROBACTER AMNIGENUS; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; EPSILOMETER TEST; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; LABORATORY TEST; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SERRATIA MARCESCENS;

ENTEROBACTERIACEAE;

EID: 84876331276     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12146     Document Type: Article

References (12)

1. Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011; 17: 1791-1798.
2. Zarfel G, Hoenigl M, Wurstl B et al. Emergence of carbapenem-resistant Enterobacteriaceae in Austria, 2001-2010. Clin Microbiol Infect 2011; 17: E5-8.
3. Giske CG, Gezelius L, Samuelsen O, Warner M, Sundsfjord A, Woodford N. A sensitive and specific phenotypic assay for detection of metallo-beta-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin. Clin Microbiol Infect 2011; 17: 552-556.
4. Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother 2012; 67: 1597-1606.
5. Glupczynski Y, Huang TD, Bouchahrouf W et al. Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals. Int J Antimicrob Agents 2012; 39: 168-172.
6. Livermore DM, Hope R, Fagan EJ, Warner M, Woodford N, Potz N. Activity of temocillin against prevalent ESBL- and AmpC-producing Enterobacteriaceae from south-east England. J Antimicrob Chemother 2006; 57: 1012-1014.
7. Dallenne C, Da Costa A, Decre D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother 2010; 65: 490-495.
8. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: twenty-first informational supplement M100-S21. PA, USA: Wayne, 2011.
9. ECDC. Risk Assessment on the Spread of Carbapenemase-producing Enterobacteriaceae (CPE) through patient transfer between healthcare facilities, with special emphasis on cross-border transfer. Stockholm, Sweden: ECDC, 2011.
10. Nordmann P, Gniadkowski M, Giske CG, Poirel L, Woodford N, Miriagou V. Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 2012; 18: 432-438.
11. Landman D, Salamera J, Singh M, Quale J. Accuracy of carbapenem nonsusceptibility for identification of KPC-possessing Enterobacteriaceae by use of the revised CLSI breakpoints. J Clin Microbiol 2011; 49: 3931-3933.
12. Cohen Stuart J, Leverstein-Van Hall MA. Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteriaceae. Int J Antimicrob Agents 2010; 36: 205-210.